The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk

Breast Cancer Research and Treatment

Volumn 131, Issue 1, 2012, Pages 27-31

  Yu, Ke Da ^a   Chen, Ao Xiang ^a   Yang, Chen ^a   Fan, Lei ^a   Huang, A Ji ^a   Shao, Zhi Ming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Breast cancer; Interleukin 10; Meta analysis; rs1800872; rs1800896

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CODOMINANCE; DOMINANT GENE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTERLEUKIN 10 GENE; PRIORITY JOURNAL; PROMOTER REGION; RECESSIVE GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK;

EID: 84856227280     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1133-3     Document Type: Article

References (30)

1. PD Pharoah AC Antoniou DF Easton BA Ponder 2008 Polygenes, risk prediction, and targeted prevention of breast cancer New Engl J Med 358 2796 2803 18579814 10.1056/NEJMsa0708739 1:CAS:528:DC%2BD1cXnvFamt7Y%3D (Pubitemid 351930854)
2. LM Dong JD Potter E White CM Ulrich LR Cardon U Peters 2008 Genetic susceptibility to cancer: the role of polymorphisms in candidate genes Jama 299 2423 2436 18505952 10.1001/jama.299.20.2423 1:CAS:528:DC%2BD1cXmsFGitL4%3D (Pubitemid 351749241)
3. DM Mosser X Zhang 2008 Interleukin-10: new perspectives on an old cytokine Immunol Rev 226 205 218 19161426 10.1111/j.1600-065X.2008.00706.x 1:CAS:528:DC%2BD1MXhsFGls7%2FP
4. R Kurzrock 2001 Cytokine deregulation in cancer Biomed Pharmacother 55 543 547 11769963 10.1016/S0753-3322(01)00140-8 1:CAS:528:DC%2BD38XltlGmsw%3D%3D (Pubitemid 34008438)
5. MJ Smyth E Cretney MH Kershaw Y Hayakawa 2004 Cytokines in cancer immunity and immunotherapy Immunol Rev 202 275 293 15546400 10.1111/j.0105-2896. 2004.00199.x 1:CAS:528:DC%2BD2MXhs1Ogsg%3D%3D (Pubitemid 39576919)
6. Z Serefoglou C Yapijakis E Nkenke E Vairaktaris 2008 Genetic association of cytokine DNA polymorphisms with head and neck cancer Oral Oncol 44 1093 1099 18486534 10.1016/j.oraloncology.2008.02.012 1:CAS:528:DC%2BD1cXhsVWhtrzF
7. WM Howell MJ Rose-Zerilli 2007 Cytokine gene polymorphisms, cancer susceptibility, and prognosis J Nutr 137 194S 199S 17182825 1:CAS:528: DC%2BD2sXms1egsw%3D%3D (Pubitemid 46052880)
8. RA Merendino A Arena AB Capozza S Chillemi M Mesiti 1996 Serum levels of interleukin-10 in patients affected by breast cancer Immunol Lett 53 59 60 8946219 10.1016/0165-2478(96)02598-9 1:CAS:528:DyaK28XmsVylt78%3D (Pubitemid 26376027)
9. KD Yu GH Di WT Yuan L Fan J Wu Z Hu ZZ Shen Y Zheng W Huang ZM Shao 2009 Functional polymorphisms, altered gene expression and genetic association link NRH: quinone oxidoreductase 2 to breast cancer with wild-type p53 Hum Mol Genet 18 2502 2517 19351655 10.1093/hmg/ddp171 1:CAS:528:DC%2BD1MXnt1eht74%3D
10. E Crawley R Kay J Sillibourne P Patel I Hutchinson P Woo 1999 Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis Arthritis Rheum 42 1101 1108 10366102 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y 1:CAS:528:DyaK1MXktVegt70%3D (Pubitemid 29268946)
11. DM Turner DM Williams D Sankaran M Lazarus PJ Sinnott IV Hutchinson 1997 An investigation of polymorphism in the interleukin-10 gene promoter Eur J Immunogenet 24 1 8 9043871 10.1111/j.1365-2370.1997.tb00001.x 1:CAS:528:DyaK2sXhsFCjsL0%3D (Pubitemid 27050850)
12. KP Economopoulos TN Sergentanis 2010 Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis Breast Cancer Res Tr 120 211 216 10.1007/s10549-009-0467-1
13. TN Sergentanis KP Economopoulos 2010 GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis Breast Cancer Res Tr 121 195 202 10.1007/s10549-009-0520-0 1:CAS:528:DC%2BC3cXkvVymtLw%3D
14. N Li J Dong Z Hu H Shen M Dai 2010 Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis Breast Cancer Res Tr 121 177 184 10.1007/s10549-009-0532-9 1:CAS:528:DC%2BC3cXkvVymtLc%3D
15. KD Yu GH Di L Fan AX Chen C Yang ZM Shao 2010 Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects Breast Cancer Res Tr 122 483 488 10.1007/s10549-009-0706-5 1:CAS:528:DC%2BC3cXnsFymtbk%3D
16. KD Yu AX Chen C Yang LX Qiu L Fan WH Xu ZM Shao 2010 Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis Breast Cancer Res Tr 122 251 257 10.1007/s10549-009-0688-3 1:CAS:528:DC%2BC3cXntlKls70%3D
17. KD Yu GH Di L Fan J Wu Z Hu ZZ Shen W Huang ZM Shao 2009 A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer FASEB J 23 2274 2287 19228880 10.1096/fj.08-124073 1:CAS:528:DC%2BD1MXosVCns78%3D
18. JK Wittke-Thompson A Pluzhnikov NJ Cox 2005 Rational inferences about departures from Hardy-Weinberg equilibrium Am J Hum Genet 76 967 986 15834813 10.1086/430507 1:CAS:528:DC%2BD2MXkslyisLw%3D (Pubitemid 40705433)
19. KD Yu GH Di L Fan ZM Shao 2009 Test of Hardy-Weinberg equilibrium in breast cancer case-control studies: an issue may influence the conclusions Breast Cancer Res Tr 117 675 677 10.1007/s10549-009-0353-x
20. LC Hartmann TA Sellers MH Frost WL Lingle AC Degnim K Ghosh RA Vierkant SD Maloney VS Pankratz DW Hillman VJ Suman J Johnson C Blake T Tlsty CM Vachon LJ Melton 3rd DW Visscher 2005 Benign breast disease and the risk of breast cancer New Engl J Med 353 229 237 16034008 10.1056/NEJMoa044383 1:CAS:528:DC%2BD2MXmt1KmsrY%3D (Pubitemid 41058322)
21. L Giordani P Bruzzi C Lasalandra M Quaranta F Schittulli F Della Ragione A Iolascon 2003 Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes Clin Chem 49 1664 1667 14500594 10.1373/49.10.1664 1:CAS:528:DC%2BD3sXnvVyhtL4%3D (Pubitemid 37194223)
22. KC Smith AC Bateman HM Fussell WM Howell 2004 Cytokine gene polymorphisms and breast cancer susceptibility and prognosis Eur J Immunogenet 31 167 173 15265021 10.1111/j.1365-2370.2004.00462.x 1:CAS:528:DC%2BD2cXnsFSjsr8%3D (Pubitemid 39049861)
23. D Guzowski A Chandrasekaran C Gawel J Palma J Koenig XP Wang M Dosik M Kaplan CC Chu S Chavan R Furie E Albesiano N Chiorazzi L Goodwin 2005 Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography J Biomol Tech 16 154 166 16030322
24. SP Balasubramanian IA Azmy SE Higham AG Wilson SS Cross A Cox NJ Brown MW Reed 2006 Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review BMC Cancer 6 188 16842617 10.1186/1471-2407-6-188 1:STN:280:DC%2BD28rgs1aqug%3D%3D (Pubitemid 44295087)
25. VU Onay L Briollais JA Knight E Shi Y Wang S Wells H Li I Rajendram IL Andrulis H Ozcelik 2006 SNP-SNP interactions in breast cancer susceptibility BMC Cancer 6 114 16672066 10.1186/1471-2407-6-114 (Pubitemid 46277079)
26. L Scola M Vaglica A Crivello L Palmeri GI Forte MC Macaluso A Giacalone L Di Noto A Bongiovanni C Raimondi A Accardo R Verna G Candore C Caruso D Lio S Palmeri 2006 Cytokine gene polymorphisms and breast cancer susceptibility Ann N Y Acad Sci 1089 104 109 17261759 10.1196/annals.1386.017 1:CAS:528: DC%2BD2sXhsFertL8%3D (Pubitemid 47092072)
27. G Gonullu B Basturk T Evrensel B Oral A Gozkaman O Manavoglu 2007 Association of breast cancer and cytokine gene polymorphism in Turkish women Saudi Med J 28 1728 1733 17965799 (Pubitemid 350244364)
28. F Kong J Liu Y Liu B Song H Wang W Liu 2010 Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population J Exp Clin Cancer Res 29 72 20553628 10.1186/1756-9966-29-72
29. U Langsenlehner P Krippl W Renner B Yazdani-Biuki T Eder H Koppel TC Wascher B Paulweber H Samonigg 2005 Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk Breast Cancer Res Tr 90 113 115 10.1007/s10549-004-3607-7 1:CAS:528:DC%2BD2MXivVKhs74%3D (Pubitemid 40568894)
30. PD Pharoah J Tyrer AM Dunning DF Easton BA Ponder 2007 Association between common variation in 120 candidate genes and breast cancer risk PLoS Genet 3 e42 17367212 10.1371/journal.pgen.0030042 (Pubitemid 46535758)